Stay updated on PLACARD Trial: CXD101 + Pembrolizumab in DLBCL

Sign up to get notified when there's something new on the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page.
Latest website image capture
Clouds background image

Latest updates to the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T14:41:27.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2, replacing the previous Revision: v3.4.1, and the funding-status notice has been removed.
    Difference
    0.5%
    Check dated 2026-02-11T01:57:52.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding, indicating information may not be up to date and transactions may not be processed until appropriations are enacted, with guidance to check status on cc.nih.gov and opm.gov. Updated the page revision tag to v3.4.1, replacing v3.4.0.
    Difference
    0.5%
    Check dated 2026-02-03T23:25:35.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added UI/metadata items Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; removed Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-27T21:59:21.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Footer updated to display Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T07:53:02.000Z thumbnail image
  8. Check
    107 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is displayed, replacing v3.3.1. No substantive study information appears to have changed.
    Difference
    0.1%
    Check dated 2025-12-01T15:11:46.000Z thumbnail image

Stay in the know with updates to PLACARD Trial: CXD101 + Pembrolizumab in DLBCL

Enter your email address, and we'll notify you when there's something new on the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page.